SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001140361-22-000190
Filing Date
2022-01-03
Accepted
2022-01-03 17:03:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFM14A ny20001688x2_defm14a.htm DEFM14A 2449018
2 logo_arena.jpg GRAPHIC 36799
3 logo_arenax1.jpg GRAPHIC 47446
4 logo_guggenheim.jpg GRAPHIC 14130
5 ny20001688x2_pc01.jpg GRAPHIC 563550
6 ny20001688x2_pc02.jpg GRAPHIC 547245
  Complete submission text file 0001140361-22-000190.txt   4114174
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-31161 | Film No.: 22502893
SIC: 2834 Pharmaceutical Preparations